Financhill
Sell
16

NVST Quote, Financials, Valuation and Earnings

Last price:
$16.65
Seasonality move :
-7.3%
Day range:
$16.06 - $16.86
52-week range:
$15.15 - $23.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.12x
P/B ratio:
0.95x
Volume:
2.8M
Avg. volume:
2.6M
1-year change:
-25.29%
Market cap:
$2.8B
Revenue:
$2.5B
EPS (TTM):
-$6.49

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
NVST
Envista Holdings
$645.9M $0.22 -2.29% 51.15% $21.33
ALGN
Align Technology
$999.2M $2.45 -1.71% 44.8% $254.64
BIOLQ
Biolase
$13.5M -$0.01 3.78% -99.71% $1.2000
MLSS
Milestone Scientific
$2.7M -$0.01 17.38% -66.67% --
SONX
Sonendo
-- -- -- -- --
XRAY
Dentsply Sirona
$920.3M $0.43 -10.43% 232.77% $20.20
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
NVST
Envista Holdings
$16.25 $21.33 $2.8B -- $0.00 0% 1.12x
ALGN
Align Technology
$160.51 $254.64 $11.8B 28.61x $0.00 0% 3.01x
BIOLQ
Biolase
$0.0090 $1.2000 $329.4K -- $0.00 0% 0.00x
MLSS
Milestone Scientific
$0.92 -- $71.7M -- $0.00 0% 8.13x
SONX
Sonendo
-- -- -- -- $0.00 0% --
XRAY
Dentsply Sirona
$15.33 $20.20 $3.1B -- $0.16 4.18% 0.82x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
NVST
Envista Holdings
32.21% 1.056 41.98% 1.63x
ALGN
Align Technology
-- 2.453 -- 1.02x
BIOLQ
Biolase
142.17% 1.859 714.45% 0.23x
MLSS
Milestone Scientific
-- 2.706 -- 1.42x
SONX
Sonendo
-- 0.000 -- --
XRAY
Dentsply Sirona
52.37% 0.344 56.57% 0.55x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
NVST
Envista Holdings
$372.5M $67.7M -22.7% -32.33% 7.11% $123.8M
ALGN
Align Technology
$696.9M $177.1M 11.12% 11.12% 17.79% $263.1M
BIOLQ
Biolase
$4.4M -$695K -129.74% -21668.17% -7.48% -$4.5M
MLSS
Milestone Scientific
$1.8M -$1.5M -61.33% -61.33% -58.44% -$973.9K
SONX
Sonendo
-- -- -- -- -- --
XRAY
Dentsply Sirona
$446M $9M -18.42% -32.39% -56.02% $36M

Envista Holdings vs. Competitors

  • Which has Higher Returns NVST or ALGN?

    Align Technology has a net margin of 0.18% compared to Envista Holdings's net margin of 10.43%. Envista Holdings's return on equity of -32.33% beat Align Technology's return on equity of 11.12%.

    Company Gross Margin Earnings Per Share Invested Capital
    NVST
    Envista Holdings
    57.05% $0.01 $4.3B
    ALGN
    Align Technology
    70.03% $1.39 $3.9B
  • What do Analysts Say About NVST or ALGN?

    Envista Holdings has a consensus price target of $21.33, signalling upside risk potential of 31.28%. On the other hand Align Technology has an analysts' consensus of $254.64 which suggests that it could grow by 58.64%. Given that Align Technology has higher upside potential than Envista Holdings, analysts believe Align Technology is more attractive than Envista Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    NVST
    Envista Holdings
    3 10 1
    ALGN
    Align Technology
    9 5 0
  • Is NVST or ALGN More Risky?

    Envista Holdings has a beta of 1.326, which suggesting that the stock is 32.59% more volatile than S&P 500. In comparison Align Technology has a beta of 1.687, suggesting its more volatile than the S&P 500 by 68.738%.

  • Which is a Better Dividend Stock NVST or ALGN?

    Envista Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Align Technology offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Envista Holdings pays -- of its earnings as a dividend. Align Technology pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NVST or ALGN?

    Envista Holdings quarterly revenues are $652.9M, which are smaller than Align Technology quarterly revenues of $995.2M. Envista Holdings's net income of $1.2M is lower than Align Technology's net income of $103.8M. Notably, Envista Holdings's price-to-earnings ratio is -- while Align Technology's PE ratio is 28.61x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Envista Holdings is 1.12x versus 3.01x for Align Technology. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NVST
    Envista Holdings
    1.12x -- $652.9M $1.2M
    ALGN
    Align Technology
    3.01x 28.61x $995.2M $103.8M
  • Which has Higher Returns NVST or BIOLQ?

    Biolase has a net margin of 0.18% compared to Envista Holdings's net margin of -13.16%. Envista Holdings's return on equity of -32.33% beat Biolase's return on equity of -21668.17%.

    Company Gross Margin Earnings Per Share Invested Capital
    NVST
    Envista Holdings
    57.05% $0.01 $4.3B
    BIOLQ
    Biolase
    40.39% -$0.04 $12.4M
  • What do Analysts Say About NVST or BIOLQ?

    Envista Holdings has a consensus price target of $21.33, signalling upside risk potential of 31.28%. On the other hand Biolase has an analysts' consensus of $1.2000 which suggests that it could grow by 22122.22%. Given that Biolase has higher upside potential than Envista Holdings, analysts believe Biolase is more attractive than Envista Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    NVST
    Envista Holdings
    3 10 1
    BIOLQ
    Biolase
    1 1 0
  • Is NVST or BIOLQ More Risky?

    Envista Holdings has a beta of 1.326, which suggesting that the stock is 32.59% more volatile than S&P 500. In comparison Biolase has a beta of 0.817, suggesting its less volatile than the S&P 500 by 18.311%.

  • Which is a Better Dividend Stock NVST or BIOLQ?

    Envista Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Biolase offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Envista Holdings pays -- of its earnings as a dividend. Biolase pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NVST or BIOLQ?

    Envista Holdings quarterly revenues are $652.9M, which are larger than Biolase quarterly revenues of $10.9M. Envista Holdings's net income of $1.2M is higher than Biolase's net income of -$1.4M. Notably, Envista Holdings's price-to-earnings ratio is -- while Biolase's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Envista Holdings is 1.12x versus 0.00x for Biolase. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NVST
    Envista Holdings
    1.12x -- $652.9M $1.2M
    BIOLQ
    Biolase
    0.00x -- $10.9M -$1.4M
  • Which has Higher Returns NVST or MLSS?

    Milestone Scientific has a net margin of 0.18% compared to Envista Holdings's net margin of -58.13%. Envista Holdings's return on equity of -32.33% beat Milestone Scientific's return on equity of -61.33%.

    Company Gross Margin Earnings Per Share Invested Capital
    NVST
    Envista Holdings
    57.05% $0.01 $4.3B
    MLSS
    Milestone Scientific
    73.05% -$0.02 $7.2M
  • What do Analysts Say About NVST or MLSS?

    Envista Holdings has a consensus price target of $21.33, signalling upside risk potential of 31.28%. On the other hand Milestone Scientific has an analysts' consensus of -- which suggests that it could grow by 131%. Given that Milestone Scientific has higher upside potential than Envista Holdings, analysts believe Milestone Scientific is more attractive than Envista Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    NVST
    Envista Holdings
    3 10 1
    MLSS
    Milestone Scientific
    0 0 0
  • Is NVST or MLSS More Risky?

    Envista Holdings has a beta of 1.326, which suggesting that the stock is 32.59% more volatile than S&P 500. In comparison Milestone Scientific has a beta of 1.409, suggesting its more volatile than the S&P 500 by 40.929%.

  • Which is a Better Dividend Stock NVST or MLSS?

    Envista Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Milestone Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Envista Holdings pays -- of its earnings as a dividend. Milestone Scientific pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NVST or MLSS?

    Envista Holdings quarterly revenues are $652.9M, which are larger than Milestone Scientific quarterly revenues of $2.5M. Envista Holdings's net income of $1.2M is higher than Milestone Scientific's net income of -$1.5M. Notably, Envista Holdings's price-to-earnings ratio is -- while Milestone Scientific's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Envista Holdings is 1.12x versus 8.13x for Milestone Scientific. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NVST
    Envista Holdings
    1.12x -- $652.9M $1.2M
    MLSS
    Milestone Scientific
    8.13x -- $2.5M -$1.5M
  • Which has Higher Returns NVST or SONX?

    Sonendo has a net margin of 0.18% compared to Envista Holdings's net margin of --. Envista Holdings's return on equity of -32.33% beat Sonendo's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    NVST
    Envista Holdings
    57.05% $0.01 $4.3B
    SONX
    Sonendo
    -- -- --
  • What do Analysts Say About NVST or SONX?

    Envista Holdings has a consensus price target of $21.33, signalling upside risk potential of 31.28%. On the other hand Sonendo has an analysts' consensus of -- which suggests that it could fall by --. Given that Envista Holdings has higher upside potential than Sonendo, analysts believe Envista Holdings is more attractive than Sonendo.

    Company Buy Ratings Hold Ratings Sell Ratings
    NVST
    Envista Holdings
    3 10 1
    SONX
    Sonendo
    0 0 0
  • Is NVST or SONX More Risky?

    Envista Holdings has a beta of 1.326, which suggesting that the stock is 32.59% more volatile than S&P 500. In comparison Sonendo has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock NVST or SONX?

    Envista Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sonendo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Envista Holdings pays -- of its earnings as a dividend. Sonendo pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NVST or SONX?

    Envista Holdings quarterly revenues are $652.9M, which are larger than Sonendo quarterly revenues of --. Envista Holdings's net income of $1.2M is higher than Sonendo's net income of --. Notably, Envista Holdings's price-to-earnings ratio is -- while Sonendo's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Envista Holdings is 1.12x versus -- for Sonendo. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NVST
    Envista Holdings
    1.12x -- $652.9M $1.2M
    SONX
    Sonendo
    -- -- -- --
  • Which has Higher Returns NVST or XRAY?

    Dentsply Sirona has a net margin of 0.18% compared to Envista Holdings's net margin of -47.51%. Envista Holdings's return on equity of -32.33% beat Dentsply Sirona's return on equity of -32.39%.

    Company Gross Margin Earnings Per Share Invested Capital
    NVST
    Envista Holdings
    57.05% $0.01 $4.3B
    XRAY
    Dentsply Sirona
    49.28% -$2.16 $4.1B
  • What do Analysts Say About NVST or XRAY?

    Envista Holdings has a consensus price target of $21.33, signalling upside risk potential of 31.28%. On the other hand Dentsply Sirona has an analysts' consensus of $20.20 which suggests that it could grow by 31.77%. Given that Dentsply Sirona has higher upside potential than Envista Holdings, analysts believe Dentsply Sirona is more attractive than Envista Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    NVST
    Envista Holdings
    3 10 1
    XRAY
    Dentsply Sirona
    2 11 0
  • Is NVST or XRAY More Risky?

    Envista Holdings has a beta of 1.326, which suggesting that the stock is 32.59% more volatile than S&P 500. In comparison Dentsply Sirona has a beta of 0.976, suggesting its less volatile than the S&P 500 by 2.383%.

  • Which is a Better Dividend Stock NVST or XRAY?

    Envista Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dentsply Sirona offers a yield of 4.18% to investors and pays a quarterly dividend of $0.16 per share. Envista Holdings pays -- of its earnings as a dividend. Dentsply Sirona pays out -13.85% of its earnings as a dividend.

  • Which has Better Financial Ratios NVST or XRAY?

    Envista Holdings quarterly revenues are $652.9M, which are smaller than Dentsply Sirona quarterly revenues of $905M. Envista Holdings's net income of $1.2M is higher than Dentsply Sirona's net income of -$430M. Notably, Envista Holdings's price-to-earnings ratio is -- while Dentsply Sirona's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Envista Holdings is 1.12x versus 0.82x for Dentsply Sirona. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NVST
    Envista Holdings
    1.12x -- $652.9M $1.2M
    XRAY
    Dentsply Sirona
    0.82x -- $905M -$430M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Is Buffett Buying and Selling Now?
What Is Buffett Buying and Selling Now?

In Q4 of last year, Warren Buffett made a few…

3 Safest Stocks to Buy Now
3 Safest Stocks to Buy Now

With the S&P 500 now in correction and stocks selling…

Tesla Stock: The Bear Case
Tesla Stock: The Bear Case

The recent stock market drop has been a punishing time…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Sell
47
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Alerts

Sell
5
CABO alert for Mar 14

Cable One [CABO] is down 3.97% over the past day.

Sell
38
ADBE alert for Mar 14

Adobe [ADBE] is up 4.43% over the past day.

Sell
29
CAR alert for Mar 14

Avis Budget Group [CAR] is up 11.68% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock